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Background: The runt-related transcription factor 1 (RUNX1) gene is a transcription factor that acts as a master regulator
of hematopoiesis and represents one of the most frequent targets of chromosomal rearrangements in human leukemias.
The t(7;21)(p22;q22) rearrangement generating a 5′RUNX1-3′USP42 fusion transcript has been reported in two cases of
pediatric acute myeloid leukemia (AML) and further in eight adult cases of myeloid neoplasms. We describe the first case
of adult AML with a 5′RUNX1-3′USP42 fusion gene generated by an insertion event instead of chromosomal translocation.
Methods: Conventional and molecular cytogenetic analyses allowed the precise characterization of the chromosomal
rearrangement and breakpoints identification. Gene expression analysis was performed by quantitative real-time PCR
experiments, whereas bioinformatic studies were carried out for revealing structural genomic characteristics of breakpoint
regions.
Results: We identified an adult AML case bearing a ins(21;7)(q22;p15p22) generating a 5′RUNX1-3′USP42 fusion gene on
der(21) chromosome and causing USP42 gene over-expression. Bioinformatic analysis of the genomic regions involved in
ins(21;7)/t(7;21) showed the presence of interchromosomal segmental duplications (SDs) next to the USP42 and RUNX1
genes, that may underlie a non-allelic homologous recombination between chromosome 7 and 21 in AML.
Conclusions: We report the first case of a 5′RUNX1-3′USP42 chimeric gene generated by a chromosomal cryptic insertion
in an adult AML patient. Our data revealed that there may be a pivotal role for SDs in this very rare but recurrent
chromosomal rearrangement.
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The runt-related transcription factor 1 (RUNX1) gene
is a transcription factor that acts as a master regulator
of hematopoiesis and is crucial for the regulation of
adult hematopoiesis and differentiation of committed
cells of various lineages [1-3]. It is one of the most
frequent targets of chromosomal rearrangements in
human leukemias, in fact, more than 30 chromosomal
translocations involving RUNX1 have been described* Correspondence: francesco.albano@uniba.it
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available in this article, unless otherwise stated[4]. The t(7;21)(p22;q22) rearrangement was first
reported in 2006 in a case of pediatric acute myeloid
leukemia (AML) [5]. This kind of chromosomal transloca-
tion generates a 5′RUNX1-3′USP42 fusion transcript,
containing the first 5 to 7 exons of RUNX1 fused to exon
3 of ubiquitin specific peptidase 42 (USP42) gene on the
der(7) chromosome. To date, the t(7;21)(p22;q22) re-
arrangement has been reported in another AML child [6],
and in nine adult cases of myeloid neoplasms (1 myelo-
dysplastic syndrome and 8 AML) harbouring the 5′
RUNX1-3′USP42 chimeric transcript [7-11]. The inci-
dence rate of this rare but recurrent abnormality has beenLtd.; licensee BioMed Central Ltd. This is an Open Access article distributed
tribution License (http://creativecommons.org/licenses/by/4.0), which permits
n in any medium, provided the original work is properly credited. The Creative
http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
.
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AML series [9,10]. Segmental duplications (SDs), account-
ing for about 10% of the human genome, are DNA
sequences larger than 1 kb, found at least twice with a
more than 90% sequence similarity in the genome [12].
We report the first case of adult AML with a 5′RUNX1-3′
USP42 fusion gene generated by an insertion event instead
of chromosomal translocation. The structural characteris-
tics of the genomic regions involved in ins(21;7)/t(7;21)
were revealed by bioinformatic analysis, and the role of
SDs in the chromosomal rearrangement is discussed.
Case presentation
A 65-year-old male was admitted to our department with
anemia, leukopenia and thrombocytopenia (hemoglobin
8.7 g/dL, total leukocytes 1.48 × 109/L, and platelets
98 × 109/L) and fever. A peripheral blood film showed
circulating blast cells (12%). The bone marrow exhibited
44% of myeloid blast cells and immunophenotypic analysis
showed that blast cells were positive for HLA-DR, CD4,
CD5, CD7, CD13, CD33, CD34, CD11b, CD117 and
CD56. Karyotypic analysis revealed 46,XY,t(7;21)(p?15;
q22) [12] /46,idem,del(5q)(q22q35) [8] (Figure 1A,B).
Molecular analysis did not show NPM1 and FLT3 gene mu-
tations. A diagnosis of AML with maturation (M2 subtype)
and “AML NOS” was made according to the FAB and the
2008 WHO criteria, respectively. He was started on an
induction treatment regimen containing daunorubicin
and cytosine arabinoside but did not obtain complete
hematologic remission. After two courses of fludarabine,
cytarabine, granulocyte colony-stimulating factor, and
idarubicin (FLAG-IDA), complete hematological remis-
sion was achieved. At this time banding analysis showed a
normal karyotype. The patient started maintainance ther-
apy with azacytidine (75 mg/m2 s.c., day 1 to 7, repeated
every 28 days). After 5 cycles of hypomethylating agent
the patient is doing well; he is still in hematological and
cytogenetic complete remission after eleven months from
the diagnosis.
Results
Fluorescence in situ hybridization (FISH) analysis with
whole chromosome painting (WCP) probes specific for
chromosomes 7 and 21 showed the presence of chromo-
some 7 sequences insertion on chromosome 21, rather
than a chromosomal translocation (Figure 1C). Reiterative
FISH cohybridizations were performed with 13 and 2 bac-
terial artificial chromosome (BAC) clones belonging to
chromosomes 7 and 21, respectively (Table 1). In details, a
chromosome 7 region of about 19 Mb was transferred on
chromosome 21; the distal and proximal insertion break-
points were mapped inside the BAC clone RP11-805P12
and between the clones RP11-813D23 and RP11-592D15,
respectively (Table 1; Figure 1D). The chromosome 21insertion point was localized between the overlapping
clones RP11-1006 L1 and RP11-1112A12, generating
splitting signals on der(21), due to chromosome 7 insertion
(Figure 1D). Therefore, according to FISH data the
karyotype was revised as follows: 46,XY,ins(21;7)(q22;
p15p22)[12]/46,idem,del(5q)(q22q35)[8].
The UCSC database was queried to identify genes
mapping in correspondence with chromosomal break-
points. The USP42 and cytochrome c (CYCS) genes were
mapped next to the distal and proximal chromosome 7
breakpoint regions, respectively; the RUNX1 gene was
located at the chromosome 21 insertion point. RT-PCR
experiments were carried out to verify the generation of a
possible fusion gene. Two chimeric 5′RUNX1-3′USP42
transcripts were detected, revealing an in-frame fusion of
RUNX1 exon 7 with USP42 exon 3 (Figure 1E) and an
alternative splice variant missing of RUNX1 exon 6, as
reported in previous studies [5]. Molecular analysis
performed at the time of complete remission and during
the follow up did not reveal the presence of any 5′
RUNX1-3′USP42 fusion transcript. Expression analysis of
the USP42 gene was performed as previously reported
[10]. Relative expression of the wild-type (using primers
spanning exons 2–3) and wild-type and rearranged (using
primers spanning exons 5–6) USP42 gene was analyzed in
the ins(21;7) AML case and in a pool of samples deriving
from four adult normal karyotype AML (NK-AML) and
healthy individuals, respectively. USP42 expression was
higher in the ins(21;7) sample, whereas the wild type
USP42 gene was normally expressed in all specimens
(Figure 1F).
Bioinformatic analysis of chromosome 7 and 21
sequences was performed to assess whether the presence
of SDs could explain the breakpoints clustering next to
the USP42 and RUNX1 genes. Eight paired blocks of in-
terchromosomal SDs (ranging from 3.6 kb to 13.3 kb in
size) are localized near the USP42 and RUNX1 genes, at
a distance of about 671 Kb and 2.3 Mb, respectively
(Figures 2A and 2B); these SDs have a homology ranging
from 92% to 95%. In total, the SDs7/21 and SDs21/7 en-
compass chromosomal regions of 51.9 Kb (chr7:6,872,808-
6,963,213) and 43.3 Kb (chr21:33,800,439-33,995,925),
respectively. Moreover, it is noteworthy that SDs7/21 are
present mostly in the genomic regions adjacent to the
USP42 gene breakpoints rather than being homogeneously
distributed over the entire chromosome 7. In fact, among
the nine SDs7/21 mapped on 7p, 8 were localized near the
USP42 gene, whereas among the 16 SDs21/7 identified on
21q, 8 were mapped near the RUNX1 gene (Figure 2A).
Discussion
We report for the first time a case of adult AML with the
5′RUNX1-3′USP42 fusion gene generated by a chromo-
some insertion instead of a translocation mechanism. It is
Figure 1 (See legend on next page.)
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Figure 1 Karyotypic, FISH and molecular analyses in our AML patient with the ins(21;7) rearrangement. (A) GTG-banded karyotype showing
the rearrangement between 7 and 21 chromosomes and del(5q) (indicated by arrows) (B) A partial G-banded karyogram comprising both der(7) and der
(21) chromosomes (C) FISH analysis with WCP probes specific for chromosomes 7 and 21 showing chromosome 7 insertion on chromosome 21; (D) FISH
experiment with the overlapping clones RP11-1006 L1 and RP11-1112A12 and BAC clone RP11-805P12 showed a fusion signal on der(21) identifying ins
(21;7) breakpoints; (E) Partial sequence chromatogram showing that RUNX1 exon 7 is fused to USP42 exon 3 in the 5′RUNX1-3′USP42 transcript. (F) Graphic
representation of USP42 gene relative expression using primers specific for wild-type (red), and wild-type and rearranged USP42 gene (blue) in the AML
patient with ins(21;7), in the NK-AML pool, and in normal bone marrow (NBM) samples.
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tion relative to the der(21) centromere, the generation of
this fusion gene can be explained by hypothesizing a direct
insertion. The ins(21;7)(q22;p15p22) rearrangement showed
three chromosomal breaks: the first two delimited the
inserted segment from the donor chromosome 7 and the
last one represents the insertion site of the recipient
chromosome 21. Moreover, in our case the 5′RUNX1-3′
USP42 fusion gene is localized on der(21) instead of der(7)
chromosome as in patients with the t(7;21) translocation.
Noteworthy, as previously reported in literature, the recip-
rocal gene 5′USP42-3′RUNX1 generated by t(7;21)(p22;
q22) results to be an inactive fusion; accordingly, our case
showing ins(21;7)(q22;p15p22) without the generation of
the reciprocal chimeric gene, underlines that the 5′
USP42-3′RUNX1 fusion is irrelevant in AML or MDS
pathogenesis. Among patients bearing the 5′RUNX1-3′
USP42 chimeric gene, the mechanism of insertion at the
basis of this kind of rearrangement can be estimated to
have a frequency of approximately 8%. In this respect, the
insertion mechanism rather than translocation represents
a rare but probable finding in cases of myeloid neoplasms
associated with recurrent and more frequent chimericTable 1 BAC clones specific for 7 and 21 chromosomes emplo















chr21 RP11-1006 L1 21q22.12
RP11-1112A12 21q22.12genes. For example, PML-RARα, BCR-ABL1 and RUNX1-
ETO fusion genes occurred with the insertion mechanism
in 2%, 1% and up to 7%, respectively [13-15].
The pathogenetic consequences of the 5′RUNX1-3′
USP42 rearrangement are very hard to define, since the
USP42 functions are not known. In fact, only two papers
[16,17] reported a role for the USP42 protein, that is a
typical deubiquitinating enzyme, with an important role in
mouse embryonic development and in p53 regulation.
The 5′RUNX1-3′USP42 transcripts encode for a predicted
fusion protein retaining the Runt homology domain
(RHD), responsible for DNA binding and heterodimeriza-
tion with core-binding factor β, and the USP42 catalytic
ubiquitin carboxyl terminal hydroxylase domain [5]. The
leukemogenic effect of the RUNX1-USP42 fusion pro-
tein could on one hand be mediated by the dominant-
negative inhibitor effect exerted by the RHD domain on
the wild-type RUNX1, as reported in other RUNX1
fusion genes [4], and on the other, an impairment of
USP42 function could be responsible for the decreased
p53 stability.
As already described in the majority of cases with the t
(7;21), our ins(21;7) AML case did not achieve completeyed in FISH experiments
Genomic position FISH pattern Gene
chr7:4159942-4322618 7 + der(7)
chr7:6072298-6252931 7 + der(7) + der(21) USP42
chr7:11526052-11672952 7 + der(21)
ch7:11781726-11941594 7 + der(21)
chr7:12165551-12320344 7 + der(21)
chr7:23006915-23182963 7 + der(21)
chr7:24053299-24226167 7 + der(21)
chr7:24242037-24409805 7 + der(21)
chr7:24523094-24692661 7 + der(21)
chr7:24690895-24865841 7 + der(21)
chr7:24982844-25163193 7 + der(21) CYCS
chr7:25104279-25278205 7 + der(7) CYCS
chr7:25162655-25322016 7 + der(7)
chr21:36046283-36237181 21 + der(21) RUNX1
chr21:36323576-36469247 21 + der(21) RUNX1
Figure 2 (See legend on next page.)
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Figure 2 Schematic diagram of SDs7/21 and SDs21/7 mediating the chromosomes 7 and 21 rearrangement. (A) SDs7/21 and SDs21/7
distribution along the p and q arms, respectively; SDs located next to USP42 and RUNX1 genes are indicated by square boxes; (B) Detailed
genomic organization of SDs7/21 (green) and SDs21/7 (red) adjacent to the USP42 and RUNX1 genes is reported. The ends of the segments that
constitute each duplication are indicated by capital letters whereas the horizontal black line represents not duplicated genomic regions. The size
of each segment and of single copy sequences is reported in Kb. (C) Hypothetical mechanism at the basis of the 5′RUNX1-3′USP42 fusion gene
generation. The two SDs blocks, SDs7/21 (A-H, in green) and SDs21/7 (A’-H’, in red), promote the approach of chromosomes 7 and 21 and
mediate the rearrangement (translocation/insertion) generating the 5′RUNX1-3′USP42 chimeric gene.
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that the 5′RUNX1-3′USP42 rearrangement could identify
a category of high-risk AML patients. However, our pa-
tient has maintained complete remission after the second
line of therapy, thanks to a hypomethylating-based main-
tenance treatment. Too few data are currently available to
assert that leukemic cells bearing the 5′RUNX1-3′USP42
rearrangement may be more sensitive to other chemother-
apy drugs rather than standard induction treatment.
In terms of SDs distribution across the genome, there
are profound differences within chromosomes. Apart from
large SD clusters in the subtelomeric and pericentromeric
regions of most chromosomes, SDs can also accumulate
in interstitial hubs [18]. These hubs are characterized by
an increased genomic instability and may be accountable
for a non-allelic homologous recombination (NAHR).
Therefore, NAHR may be driven by breakpoint-flanking
SDs, which can misalign in meiosis due to their sequence
homology [19]. Genotype–phenotype relationships for
NAHR-mediated rearrangements are well-known, and in
recurrent constitutional chromosomal rearrangements are
associated with congenital human genomic disorders
[19-21]. However, the role of SDs in genomic rearrange-
ments associated with cancer is still virtually unknown. In
this regard, it has been reported that the isochromosome i
(17q) generation in cancer is due to the presence of SDs
in correspondence with the chromosomal breakpoints
[22]. Moreover, recently our group showed the involve-
ment of SDs in the genesis of the t (9;22) translocation
and in the occurrence of genomic deletions on the der(9)
chromosome in chronic myeloid leukemia [23]. In our
current report we describe the presence of interchromo-
somal SDs next to USP42 and RUNX1 genes that could be
at the basis of NAHR between chromosome 7 and 21 in
AML (Figure 2A-C). In fact, the two SDs blocks could
promote chromosomes 7 and 21 approach, triggering the
NAHR mechanism and the 5′RUNX1-3′USP42 fusion
gene generation. In this context, it is very hard to identify
the circumstances determining the translocation instead
of insertion. This observation has already been made [5]
but we report for the first time the detailed SDs
organization in the genomic region involved in the 5′
RUNX1-3′USP42 rearrangement (Figure 2A-C). The
relationship between the two SDs blocks and the break-
points on chromosome 7 and 21 appears anything butrandom considering the fact that the t(7;21)(p22;q22) in
AML is a very rare but recurrent rearrangement. A link
between nuclear architecture, in terms of chromatin
organization, and SDs across the chromosome 7 has been
recently demonstrated [24]. What might be the circum-
stances that favor a chromosome pairing mediated by SDs
in AML is something still to be clarified.
Conclusions
We report the first case of a 5′RUNX1-3′USP42 chimeric
gene generated by a chromosomal cryptic insertion in an
adult AML patient. Our data reveal that it is possible that
there may be a pivotal role for SDs at the basis of this very




Karyotyping was performed at diagnosis on bone marrow
cells according to standard methods. The bone marrow
cells were cultured for 24–48 hours, and chromosomes
were G-banded with trypsin–Giemsa staining (GTG-
banded) according to the recommendations of the Inter-
national System for Human Cytogenetic Nomenclature
[25]. At least 20 metaphases were analyzed.
FISH analysis
FISH analyses were performed on BM samples at the
onset of AML, using WCP and BAC probes selected ac-
cording to the University of California Santa Cruz (UCSC
http://genome.ucsc.edu/; Feb. 2009 release) database.
Chromosome preparations were hybridized in situ with
probes labeled by nick translation [26].
Molecular analyses
Total RNA derived from bone marrow (BM) cells was
reverse transcribed into cDNA using the QuantiTect
reverse transcription kit (Qiagen, Chatsworth, CA, USA).
PCR for detection of the chimaeric 5′RUNX1-3′USP42
transcript was performed with the previously reported
primers [5]. The amplification was achieved using the
following cycling parameters: 95°C for 30 sec, 60°C for
45 sec, and 72°C for 1 min for 35 cycles. Amplification
product was run, excised, and extracted from a 2% agarose
gel. Products were purified using the QIAquick gel
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structions and sequenced by Sanger sequencing.
Gene expression analysis was carried out by quantitative
real-time PCR (qRT-PCR) experiments using the LightCy-
cler 480 SYBR Green I Master mix on the LightCycler
480II (Roche Diagnostics, Indianapolis, IN, USA). All
samples were run in triplicate as technical replicates.
The β-glucuronidase (β-GUS) gene was employed as
endogenous control and a pool of cDNA derived from
healthy individuals BM cells was used as calibrator.
Amplifications were carried out at 95°C for 10 min,
followed by 45 cycles at 95°C (10 sec), 60°C (30 sec),
72°C (1 sec). Advanced relative quantification analysis
was performed using LightCycler 480 Software 1.5.1,
based on the ΔΔCt method. For USP42 gene expression
analysis the previously reported primers were used [10].Bioinformatic analysis
The UCSC Table Browser (http://genome.ucsc.edu/cgi-bin/
hgTables) was queried using the track ‘Segmental Dups’ to
check for the presence of SDs on chromosomes 7 and 21.
The analysis was restricted to the search for interchromo-
somal SDs with homology for chromosome 21 (SDs7/21,
mapped on chromosome 7) and 7 (SDs21/7, mapped on
chromosome 21).Ethics statement
This study was performed in agreement with the
Declaration of Helsinki, and approved by the local
Ethical Committee (Azienda Ospedaliero Universitaria –
Policlinico di Bari) . Written informed consent was ob-
tained from the patient for publication of this Case report
and any accompanying images. A copy of the written con-
sent is available for review by the Editor of this journal.
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